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Background: Different types of reactive oxygen metabolites (ROMs) are known to be involved in carcinogenesis.
Several studies have emphasized the formation of ROMs in ischemic tissues and in cases of inflammation. The
increased amounts of ROMs in tumor tissues can either be because of their causative effects or because they are
produced by the tumor itself. Our study aimed to investigate and compare the levels of ROMs in tumor tissue and
adjacent lung parenchyma obtained from patients with lung cancer.
Methods: Fifteen patients (all male, mean age 63.6 ± 9 years) with non-small cell lung cancer were enrolled in the
study. All patients were smokers. Of the patients with lung cancer, twelve had epidermoid carcinoma and three had
adenocarcinoma. During anatomical resection of the lung, tumor tissue and macroscopically adjacent healthy lung
parenchyma (control) that was 5 cm away from the tumor were obtained. The tissues were freshly frozen and
stored at −20°C. The generation of ROMs was monitored using luminol- and lucigenin-enhanced
chemiluminescence (CL) techniques.
Results: Both luminol (specific for .OH, H2O2, and HOCl
-) and lucigenin (selective for O2
.-) CL measurements were
significantly higher in tumor tissues than in control tissues (P <0.001). Luminol and lucigenin CL measurements were
1.93 ± 0.71 and 2.5 ± 0.84 times brighter, respectively, in tumor tissues than in the adjacent parenchyma (P = 0.07).
Conclusion: In patients with lung cancer, all ROM levels were increased in tumor tissues when compared with the
adjacent lung tissue. Because the increase in lucigenin concentration, which is due to tissue ischemia, is higher than
the increase in luminol, which is directly related to the presence and severity of inflammation, ischemia may be more
important than inflammation for tumor development in patients with lung cancer.
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Lung cancer, which is the most common cause of cancer
deaths worldwide among both men and women, accounts
for 28% of cancer deaths and approximately 6% of all
deaths [1]. Tobacco smoke is the main cause of lung cancer
and is responsible for 87% of all lung cancers in the United
States [1,2]. The risk increases with the amount of tobacco
used and the length of time for which it has been used.
Cigarette smoke, a major source of exogenous oxidants,
leads to chronic airway inflammation with accumulation* Correspondence: hacerkuzu@hotmail.com
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reproduction in any medium, provided the orand activation of leucocytes, which produce high levels of
reactive oxygen metabolites (ROMs) and nitric oxide [3,4].
Lung tissue is protected against these oxidants by a var-
iety of antioxidant mechanisms such as superoxide dis-
mutases. An imbalance between oxidant and antioxidant
levels induces oxidative stress in lung tissues [5]; thus,
excessive and inappropriate production of endogenous
and/or exogenous reactive oxygen species and nitric
oxide is implicated in the pathogenesis of lung cancer
[1,6,7]. Free radicals are well-known mutagenic agents
and cause genotypic changes that may lead to the devel-
opment of cancer [8].
Although it is difficult to quantitate ROMs because of
their short-lived and reactive nature, the chemiluminescenced. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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producible technique. The two CL probes, luminol and
lucigenin, differ in their selectivity. Lucigenin is particu-
larly sensitive to the superoxide radical (O2
.-), whereas
luminol detects hydrogen peroxide (H2O2), hydroxyl radi-
cals (.OH), hypochlorite (ClO-), peroxynitrite (ONOO-),
and lipid peroxyl radicals [9].
Detection of high levels of ROMs, which are known to
be increased by ischemia or inflammation, in tumor tis-
sues may be attributable either to their role in the eti-
ology of cancer or to the presence of the tumor itself.
The present study was designed to explore the intensity
of oxidative stress in patients with lung cancer by asses-
sing the generation of ROMs in tumor and normal lung




Fifteen consecutive patients with non-small cell lung
carcinoma who were operated on in our clinic were
included in the study. All patients were smokers and had
no preoperative neoadjuvant treatment and no previous
history of carcinoma of any type. Patients with tumors
less than 2 cm in size or endobronchial tumors were not
included because obtaining a 1-cm sample from such a
small tumor might disturb the pathological examination.
After routine preoperative evaluation and staging, the
patients underwent anatomical lung resection (either lobec-
tomy or pneumonectomy) together with mediastinal lymph
node dissection. Informed consent of the patients and
approval of the ethics committee of Marmara University
Medical School were obtained.
Experimental design
Immediately after completion of lung resection and re-
moval of the surgical specimen, two tissue samples were
obtained from each patient: the first sample was obtained
from the lung tumor and the second was obtained from
adjacent lung parenchyma (for the control group) at least
5 cm away from the gross margin of the lung tumor. The
tissues were then washed with saline (0.9% NaCl) to re-
move blood, freshly frozen, and stored at −20°C until they
were examined.
Chemiluminescence measurement
To assess the role of ROMs in this study, CL derived
from luminol and lucigenin was measured as an indica-
tor of radical formation. CL measurements are based on
light emission with specific enhancers such as luminol,
lucigenin, luciferase, and horseradish peroxidase. The
benefits of this method include rapidity, ultrasensitive
detection limits, and broad applicability. In clinical re-
search, the sensitivity of this method has led to its use ina wide range of applications, especially those that involve
monitoring of reactive oxygen species [10].
In our experiment, tissues were thawed and washed
with saline. Luminescence of the tissue samples was
recorded at room temperature using a Junior LB 9509
luminometer (EG&G Berthold, Bad Wildbad, Germany) in
the presence of enhancers. Tissue specimens were cut into
two pieces and placed into tubes containing PBS-HEPES
buffer (0.5 mol/L phosphate buffered saline containing 20
mmol/L HEPES, pH 7.2). ROMs were quantitated after
addition of the enhancer (lucigenin or luminol) to a final
concentration of 0.2 mmol/L. After the measurements
were made, the tissues were removed from the tubes, dried
on filter papers, and weighed. All chemiluminometric
counts were obtained at 1-min intervals for 5 min, and the
results were expressed as areas under the curve (AUCs) of
relative light units (rlu) for 5 min per mg of tissue [9]. The
calculation was based on the integration of the curve using
the trapezoidal rule (a linear approximation).
Statistical analysis
The various degrees of oxidative stress in different types of
lung tumors, including epidermoid carcinoma and adeno-
carcinoma, and adjacent lung tissues were statistically ana-
lyzed. All data are expressed as means ± SEM. Groups of
data were compared using a paired t test. The results were
considered significant when the P value was less than 0.05.
Calculations were performed using GraphPad Prism 3.0
(GraphPad Software, San Diego, CA, USA).
Results and discussion
We examined a total of 15 patients, all of whom were
male with a mean age of 63.6 ± 9 years (range 48 to 74
years). Patients’ characteristics are summarized in Table 1.
In all patients, the lucigenin and luminol CL values were
higher in cancerous lung tissues than in adjacent lung tis-
sues. The luminol CL level in tumor tissues was signi-
ficantly higher than that in control tissues (4.32 ± 0.38 rlu/
mg tissue vs. 2.26 ± 0.22 rlu/mg tissue, P <0.001)
(Figure 1a). Similarly, the lucigenin CL level showed a
marked increase in the tumor tissues as compared to con-
trol tissues (4.49 ± 0.44 rlu/mg tissue vs. 1.91 ± 0.12 rlu/mg
tissue, P <0.001) (Figure 1b).
In this study, we investigated the role of oxidative
stress in lung cancer. We demonstrated that ROM
levels, as measured by the CL method, were significantly
higher in the cancerous tissues of lung cancer patients
than in control tissues obtained from the same patients.
The antitumor defense mechanisms of the body result in
continuous oxidative stress and inflammatory responses,
which contribute to the various types of oxidative damage
observed in lung cancer [11]. It may be hypothesized that
chronic injury to the epithelium caused by the production
of ROMs may lead to lung cancer. Free radicals that play a
Table 1 Characteristics of patients
Age (years) Locations TNM Histological type
1 59 RUL T2N0M0 Adeno ca
2 73 RUL T1N1M0 Epid ca
3 71 LLL T1N1M0 Epid ca
4 65 RUL T1N0M0 Epid ca
5 58 RUL T1N1M0 Epid ca
6 65 RUL T2N1M0 Adeno ca
7 60 RLL T1N1M0 Epid ca
8 74 RML T2N0M0 Epid ca
9 49 LLL T2N1M0 Adeno ca
10 72 LLL T1N1M0 Epid ca
11 78 LUL T2N0M0 Epid ca
12 53 LLL T2N0M0 Epid ca
13 67 LUL T2N1M0 Epid ca
14 62 RUL T2N0M0 Epid ca
15 48 LLL T1N1M0 Epid ca
Adeno ca, adeno carcinoma; Epid ca, epidermoid carcinoma; LLL, left lower
lobe; LUL, left upper lobe; RLL, right lower lobe; RML, right medial lobe;
RUL, right upper lobe; TNM, tumor, node, metastasis (classification system).
Figure 1 Lucigenin (a) and luminol (b) chemiluminescence (CL)
levels in the control and tumor groups. Rlu, relative light units.
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air pollution, or activated phagocytes, the latter of which
are a consequence of chronic inflammatory diseases [12].
In a report that examined lipid peroxidation in whole
blood samples obtained from patients with lung cancer,
the authors reported that the level of malondialdehyde
(MDA, a lipid peroxidation product) in patients with
early-stage (stage I and II) lung cancer was not signifi-
cantly altered compared to the control group [7]. How-
ever, in patients with advanced-stage lung cancer, the
MDA level was significantly higher. Additionally, the level
of whole blood glutathione (an intracellular antioxidant)
was decreased in patients with both early- and advanced-
stage lung cancer. In another study, the ROM levels in
serum samples from patients with small cell carcinoma,
adenocarcinoma, and epidermoid carcinoma were higher
than the levels detected in control subjects [13]. Zieba et al.
reported that lipid peroxidation was higher in cancerous
tissue samples than in normal lung parenchyma and
demonstrated that thiobarbituric acid-reactive substances,
which are markers of lipid peroxidation, were positively
correlated with both clinical stage and spontaneous gener-
ation of H2O2 in tumor tissue [4].
In our study, luminol-enhanced CL measurements were
significantly higher in tumor specimens than in adjacent
pulmonary parenchyma tissues. Our method, which is
based on the measurement of spontaneously released
ROMs, is also capable of measuring H2O2 and another sub-
stances such as hydroxyl radicals (.OH), hypochlorite ions
(ClO-), peroxynitrite ions (ONOO-), and lipid peroxyl ra-
dicals. Our results show that H2O2 and other compoundsare released from lung tumor specimens. In an animal
study, rats were exposed to cigarette smoke, and the
luminol-enhanced CL technique was used to measure
ROMs in lung and laryngeal tissues [14]. The results indi-
cated that cigarette smoking increased luminol-enhanced
CL measurements, and vitamin E decreased ROM release
significantly. H2O2 can be converted to
.OH in the presence
of metal ions via the Fenton reaction or by neutrophil infil-
tration; alternatively, it can be converted to HOCl- in the
presence of chloride ions via the myeloperoxidase enzyme.
In our study, luminol-enhanced CL amplification can also
be used to measure .OH and HOCl-. HOCl- is usually pro-
duced by polymorphonuclear leukocytes at an inflamma-
tion site. In a group of patients with non-small cell lung
cancer, myeloperoxidase activity was lower and glutathione
levels were higher in patients with malignant disease [15].
Reports of increased inflammatory markers and C-reactive
protein [16] as well as an acute phase response in cancer
patients indicate that both systemic and local (that is, at the
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with the presence of a tumor [4]. In addition, some studies
indicate that the tumor tissue itself could be the source of
ROMs and lipid peroxidation products [17].
Ischemia is the major cause of superoxide generation in
cancer tissues. Ischemia leads to glucose and adenosine tri-
phosphate (ATP) depletion, which in turn leads to a de-
crease in sodium-potassium ATPase (Na-K ATPase)
activity and causes depolarization of the cells. In these
depolarized cells, intracellular calcium increases, resulting
in activation of the xanthine-hypoxanthine system and pro-
duction of superoxide radicals. Superoxide radicals, which
are highly reactive, damage membrane phospholipids, cellu-
lar proteins, and DNA [18]. In our study, the levels of
lucigenin-enhanced CL were higher in tumor samples than
in parenchymal tissues. Formation of superoxide radicals
can be prevented via superoxide dismutase (SOD) enzymes.
In an immunohistochemical study, the expression levels of
both Mn-SOD (mitochondrial form) and Cu/Zn-SOD
(cytoplasmic or nuclear form) in the lungs of patients with
squamous cell carcinoma were significantly lower than the
expression levels of these enzymes in luminal cells and un-
involved epithelium of the same patients [19]. These results
demonstrate that intracellular and intramitochondrial
SODs are not capable of reducing superoxide radical gener-
ation, and our study also provided evidence to support this
finding based on lucigenin-enhanced CL measurements.
The monitoring of ROM generation in freshly frozen tis-
sue samples using the CL technique has been described in
two studies by Ohoi et al. [20,21]. Cicenas et al. and Toklu
et al. also used this method for freshly frozen tissue sam-
ples of breast and colon cancers as well as for urogenital
tissues [9,22,23]. Our study is the first to measure ROM
levels in lung cancer tissue samples.
A limitation of our study is the small sample size (15
patients). This was a small pilot study. Similar studies with
larger sample size, at least 100 patients, are needed to con-
firm our results.
Conclusion
In general, evidence suggests that lucigenin-enhanced
superoxide radical generation is increased by ischemia in
tissues, whereas the luminol level is increased in the pres-
ence of inflammation and is directly related to inflamma-
tory severity. In our study, the mean concentrations of
lucigenin and luminol in cancerous lung tissue were sig-
nificantly higher than their concentrations in adjacent lung
parenchyma. A higher increase in the concentration of
lucigenin compared with luminol shows that tissue ische-
mia may be more important than inflammation for tumor
development in lung cancer patients.
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